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With the growing demands on agricultural production around the world, it is becoming 
increasingly important to figure out how to feed the growing population. For thousands of years 
we have been optimizing our agricultural outputs in livestock species through reproductive 
selection based on favorable traits, many of which are due to genetic variation. Single nucleotide 
polymorphisms are responsible for a great deal of either beneficial or undesirable mutations. In 
this study, we examine how we can use the CRISPR/Cas9 system to induce single-base pair 
substitutions, thereby improving animal genetics through removal of undesirable or insertion of 
beneficial mutations.  In Angus beef cattle (Bos taurus), a mutation in the NHL-repeat 
containing 2 gene causes a heritable abnormality referred to as Developmental Duplications 
(DD). Calves homozygous for this mutation are affected with a broad range of neural tube 
defects and commonly exhibit polymelia, which is the presence of additional limbs. The 
mutation has been identified as a single-nucleotide polymorphism resulting in a valine to alanine 
substitution in a highly conserved protein-coding region of the gene. Similarly, in Holstein dairy 
cattle (Bos taurus) a guanine to adenine substitution mutation in the α-lactalbumin flanking 
region at (+15) base pairs from the transcriptional start site has been shown to be associated with 
increased quantity of milk production, likely due to upregulation of the α-lactalbumin protein 
and increased lactose synthesis. Other breeds of cattle used for dairy production, such as Nelore 
and other tropically adapted Bos indicus breeds, do not have this mutation unless they are 
crossed to Holsteins. In this study, the CRISPR/Cas9 system was paired with a guide RNA 
targeting the aforementioned genes to create a break in the DNA of fibroblast cells from Nelore 
and Angus cattle. Cells were also supplied with a 90 nucleotide single stranded-oligonucleotide 




at those loci. Cells from these cattle that are genetically improved by this technique may be used 
for somatic cell nuclear transfer and resulting embryos will be transferred to recipients. With 
these genetic improvements, we can preserve high quality beef cattle genetics while eliminating 
a harmful mutation, and we can increase milk yield of tropically adapted dairy cattle to feed 
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Chapter 1: Review of Literature 
The population of humans on earth has been increasing exponentially, and in 2050 it is 
expected to be 9 billion people. Hunger already plagues many regions of the world, and unless 
we take action, the number of hungry people will only continue to grow. Furthermore, as third 
world countries continue to develop and become more affluent, the demand for meat and animal 
products rises as a larger portion of the diet. Therefore, it is extremely important that we 
optimize the efficiency of our livestock production in order to make the most animal products 
using the fewest resources.  
Because of the growing population and expansion of urban terrain, the amount of land 
used for farming will not be able to increase, yet we will need to increase meat production from 
270 million tons annually to 470 million tons annually to meet demand by 2050 (FAO, 2016).  
This means that we cannot simply upscale current production practices; we instead must 
continuously improve our practices and use fewer resources. Over recent years, we have already 
begun to optimize the conditions for nutrition, management, and reproduction practices.  
Since the domestication of animals for livestock, humans have been selecting animals 
with desirable traits and thereby directing the evolution of the species. Some of these traits have 
included: temperament, fat content, size, growth rate, and feed conversion efficiency (Haskell, 
Simm, & Turner, 2014; Koch, Swiger, Chambers, & Gregory, 1963). The best and most valuable 
animals have been bred with each other over generations, and high quality animals are selected 
to be the pool of genetics for the next generation of offspring.  
Current reproduction methods such as artificial insemination, in vitro fertilization, and 




of the population. The widespread dissemination of superior genetics with artificial reproductive 
technologies has contributed heavily to the increase in production in recent years (Hansen, 
2014). Additionally, in 2008 the FDA approved the sale of cloned animals and their progeny for 
food and production purposes, leading to yet another reproductive technique available to 
preserve and propagate advanced genetics (FDA, 2014). 
1.1 Genetic mutations in cattle 
While there are many advantages to these reproductive methods, there are a few 
drawbacks. One prominent disadvantage to heavy individual contributions to the gene pool is 
that recessive genetic disorders emerge more readily among the population. The elite animals are 
bred with each other with the aim of creating animals homozygous for superior traits, however 
they simultaneously can become homozygous for deleterious alleles (Van Eenennaam, 2014).  
Most of these harmful alleles have emerged from mutations; errors in DNA replication 
have been the driving force for evolution, leading to immense diversity among living things over 
time. Even the smallest changes in the genetic code can have a large impact on an organism and 
its offspring. This can be beneficial as shown by evolutionary selection for favorable traits, but it 
can also have detrimental impacts. With respect to agricultural animals of high production 
quality, a mutation that goes unnoticed can become prevalent throughout the population within a 
matter of a few generations.  
Some examples of mutations, specifically in cattle, are: bovine chondrodysplastic 
dwarfism (Yoneda et al., 1999), syndactyly (Drögemüller & Distl, 2006), arthrogryposis 
multiplex or “curly calf syndrome,” neuropathic hydrocephalus, and developmental duplications 
defect (DD) (Van Eenennaam, 2014). One example of how widespread these defects can become 




significantly increased milk production, is expected to have sired 14% of the current US dairy 
population. However, he was a carrier for a single nucleotide polymorphism (SNP) nonsense 
mutation in the APAF1 gene that causes truncation of a vital protein that causes fetal death if 
inherited in a homozygous fashion. Because of artificial insemination using his semen and that of 
his offspring, the trait has become so widespread that it is estimated to have been responsible for 
525,000 abortions and costed the industry over about $400 million (Adams et al., 2016).  
Conversely, some of these mutations are responsible for favorable production traits, such 
as the slick gene that decreases heat stress, a myostatin knockout for increased muscling, 
calpastatin for increased meat tenderness, a polled gene for lack of horn development (Casas & 
Kehrli, 2016), and a single base pair substitution in the alpha-lactalbumin gene for increased 
milk yield (Bleck & Bremel, 1993a). There are 233 known Mendelian traits or disorders known 
in cattle, 133 of which have a known quantitative trait locus in the DNA (Nicholas, 2017).  
1.2 Developmental Duplications 
Developmental Duplications (DD) was first detected in Angus beef cattle on account of 
an increase frequency of malformed calves, especially those with polymelia—the presence of 
extra limbs (Denholm, Martin, & Denman, 2011). As a result, DNA from mutant calves was 
collected for a SNP chip analysis. A genome wide-association study showed that calves born 
with this defect consistently harbored the same SNP, which is a substitution mutation on exon 5 
of the NHL repeat containing 2 (NHLRC2) gene.  This SNP is a cytosine substitution for a 
thymine, which is a missense mutation in the protein coding region of the NHLRC2 gene. The 
wild type codon encodes a valine, while the mutant variant encodes an alanine, provoking an 
expected conformational change in a highly conserved region of the genome. The allele for DD 




Furthermore, the trait demonstrates incomplete penetrance, meaning that homozygous recessive 
individuals do not always show phenotypical abnormalities of DD (Denholm et al., 2016).  
Because heterozygous individuals are unaffected, and in part owing to the widespread 
dissemination of genetics through artificial reproductive technologies, the allele frequency of this 
mutation grew to 7% in Australia and 3% in the USA before it was noticed (Denholm et al., 
2016). Furthermore, it is likely that the homozygous recessive genotypes are often embryonically 
lethal, and we therefore are unable to exactly quantify the costs of this mutation. In a genotypic 
study of Angus sires, the carrier frequency was 6% in the United States; however, there were no 
homozygous individuals found, supporting the theory that homozygous recessive genotypes 
frequently may be embryonically lethal (Beever, 2013).   
1.3 NHLRC2 Gene 
The Bos taurus NHLRC2 gene is located on exon 5 of chromosome 26 and is a protein 
coding gene with 12 exons and a total of 643 amino acids (NCBI Gene:3743554). The exact 
function of the gene is still unknown, but it has been shown to be expressed in alimentary, 
cardiovascular, nervous, olfactory, and visual systems in mice (Blake et al., 2017; Finger et al., 
2017).  
Beyond the initially observed polymelia, calves with various neural tube defects have 
been confirmed to be DD recessive homozygotes. The phenotypic manifestations for DD include 
a range of neural tube defects such as: spina bifida and myemeningocoeles—sacs of spinal fluid 
protruding from the skull or spine due to lack of bone closure around the spinal cord, 
teratomas—solid tissue tumor masses, lipomas—fat filled  tumor masses,  diprosopus—facial 
duplication and abnormalities, polymelia—supernumerary limbs, and conjoined twins (Denholm 




are found in the notochord region located along the dorsal midline, from the back of the head to 
the thorax (Denholm et al., 2011). These phenotypes indicate that this mutation in the NHLRC2 
gene in bovine is a cause of neural tube defects (NTDs). 
NTDs can be attributed to a variety of factors and cause many different conditions, but 
are unified in that they are a result of improper neural tube closure (Greene & Copp, 2014). In 
early embryonic development, after formation of the primitive streak, the neural plate extends 
from cranial to caudal ends of the embryo. The neural ectoderm then migrates inward, pushing 
together to form the neural fold and neural crest, followed by folding over the neural plate to 
form the neural tube. Apoptosis was shown to be present during neural fold bending and fusion, 
dorsal neural tube remodeling post neural tube closure, and migration of neural crest cells away 
from neural tube, though cell death is not necessary for neural tube closure itself (Massa et al., 
2009). Prevention of apoptosis in any one of these events could be the cause for neural tube 
defects. A live imaging study of mouse embryonic development by Yamaguchi et al. suggests 
that a balance of apoptotic and anti-apoptotic factors at specific intervals in development are 
necessary for successful neural tube closure. In this study, the absence of apoptosis induced via 
caspase inhibitors (zVAD-fmk) or apaf1 knockout in embryos agrees with the previous study in 
that the neural tube is able to close without apoptosis, however these embryos showed a 
significantly reduced neural tube closure speed. This delay in closure could increase the 
possibility for neural tube defects to develop during that sensitive time window (Yamaguchi et 
al., 2011).  
To inhibit caspase activity, Yamaguchi et al. cultured embryos with the substrate mimetic 
caspase inhibitor zVAD-fmk, which is an irreversibly binding fluoro-methylketone synthesized 




tube closure time (Yamaguchi et al., 2011). In the amino acid sequence encoded by the NHLRC2 
gene, a similar sequence, Tyr-Val-Ala-Asp (YVAD) is found three times in the coding regions of 
bovine NHLRC2, which is conserved in other species such as mouse and human (NCBI Gene ID: 
534327). This YVAD sequence has been shown to be the binding site for caspase-1, and it has 
been shown that YVAD sequences are able suppress apoptosis by inhibiting caspase-1 or 
caspase-3-like proteases (Dorstyn, Kinoshita, & Kumar, 1998).  While the DD associated 
mutation does not appear to affect the coding of the YVAD regions, alterations in the protein 
coding regions of NHLRC2 could change the shape of the protein and cause variation in anti-
apoptotic properties of the protein.  
Disruptions in cell death pathways have been shown to be detrimental during embryonic 
development.  When the NHLRC2 locus was knocked out in a mouse model, it appeared to be 
embryonically lethal (Delhotal, 2016). Several studies show that knockouts or disruptions in the 
Caspase 3, Caspase 8, Caspase 9, or Apaf1 genes, all of which encode proteins that are important 
for apoptosis pathways, are lethal in mice. Of those, mice with Casp3, Casp9 or Apaf1 knockouts 
show neural tissue malformation such as visible ectopic masses in their heads, disfigured 
cerebrum, exencephaly, and brain overgrowth (Hakem et al., 1998; Los, Wesselborg, & Schulze-
Osthoff, 1999; Meier, Finch, & Evan, 2000; Varfolomeev et al., 1998; Woo et al., 1998; Yoshida 
et al., 1998).  
While neural tube defects and polymelia do occur in other animals, there have not been 
proven cases of DD in other species. A case of polymelia in a Holstein calf with similar 
phenotype to DD was found to be genetically unrelated (Neupane et al., 2017). However, in 
recent cases in a relatively genetically related ethnic group in Africa, there have been several 




genetically related parents. Due to the lack of DNA testing, no conclusive results can be 
determined from these cases with respect to mutation or genetic causes. However the NHLRC2 
protein is highly conserved across species, and with the similar phenotypes shown in this 
population of humans as the Angus phenotypes, there is the possibility that there is a genetic 
locus for this trait on the NHLRC2 gene in humans (Kelani et al., 2017).  
The NHLRC2 protein has recently been cited in human studies as a potential blood-based 
biomarker for Alzheimer’s disease (Long, Pan, Ifeachor, Belshaw, & Li, 2016), and furthermore 
as a potential hotspot for mutation in chronic myelomonocytic leukemia cells (Merlevede et al., 
2016). Further research must be done on this protein to uncover its function and its role in 
development.  
1.4 Polymorphisms in the α-Lactalbumin Gene 
In dairy cattle, studies are performed to establish quantitative trait loci and advantageous 
alleles for milk production. Several genetic variations at the α-Lactalblumin (LALBA) locus 
have been identified in Holstein (Bos taurus) dairy cattle. Three polymorphisms were identified 
by Bleck and Bremel in Holstein cattle in the 5’ region of the LALBA gene. Two of the 
mutations, at (+15) and (+21) base pairs 3’ from the transcriptional start site, were in the non-
coding region of the mRNA. The third, at (+54), was identified as a silent mutation in the signal 
peptide coding region of the transcript (Bleck & Bremel, 1993b)  
Further studies examined the correlation of the polymorphism at the (+15) position with 
increased milk yield in Holsteins; the single nucleotide substitution of a guanine to an adenine at 
this locus, (labeled as A, whereas the guanine variant is denoted with B), is positively correlated 
with milk yield.  AA (P< 0.05) and AB (P<0.10) genotypes produced more milk than BB 




A allele likely causes the milk to be more dilute. The proposed mechanism for this is a higher 
lactose concentration, drawing in water to increase milk volume (Bleck & Bremel, 1993b). A 
study of allele frequency in 1993 indicated that at the (+15) locus, the A allele frequency was 
32% in Holstein cattle, with 8.8% and 46.7% of the sample population of the AA and AB 
genotype, respectively (Bleck & Bremel, 1993b). Another study in 2008 examined allele 
frequency of the (+15) mutation amongst Holstein, Nelore, and Dairy Nelore populations. 
Neither beef nor dairy Nelore sample populations harbored the A allele, while this Holstein 
sample population showed a 17.6% allele frequency. While this study showed that the (+15) 
mutation is fairly specific to Holstein cattle, it did not measure its impact on milk yield (Martins 
et al., 2008). A study in 2014 examined the impact of the (+15) LALBA mutation in Bos indicus 
Sahiwal cattle in Pakistan. While there was no AA genotype found in any of the population, 
there were several individuals with an AB genotype, and an allele frequency for A of 7%. In this 
study, the AB genotype was highly correlated (P=0.07) with improved milk yield (Mir, Ullah, & 
Sheikh, 2014). This agrees with the studies done by Bleck and Bremel in 1993 indicating that A 
has a positive impact on milk yield. With a larger population size or the presence of AA 
individuals, the correlation would likely have a higher significance. These studies show that AA 
and AB genotypes at the (+15) locus in both Bos Taurus and Bos indicus cattle improves milk 
yield. Furthermore, the allele frequency of A is much higher in Holstein, and that selection for or 
introduction of this polymorphism into Bos indicus could have a positive impact on milk yield.  
1.5 Alpha-Lactalbumin and milk composition 
The protein -lactalbumin encoded at that locus is a whey protein found in milk. It is one 
of six major milk proteins, and composes about 21% of the whey milk proteins, and 4% of total 




caseins, α-lactalbumin and β-lactoglobulin are the major whey proteins. Beyond proteins, lactose 
is by far one of the most important components of milk for its roles both in milk synthesis and 
nutrition. Composing about 4.6% (w/w) of milk, and 36% of the dry matter in bovine milk, 
lactose makes up the highest proportion of the dry matter components (Walstra, 1999).  
Research suggests that the sugar lactose is a major regulator of milk synthesis. 
Membranes of the golgi, which is the site for lactose synthesis, are permeable to the 
monosaccharides glucose and UDP-galactose, which are the substrates for lactose synthesis. 
However the membranes are not permeable to the disaccharide lactose, and therefore water is 
drawn in by osmotic pressure depending on the concentration of lactose. Studies have shown that 
a short term insulin infusion (decreasing blood glucose availability, therefore limiting a key 
substrate for lactose synthesis) was shown to decrease milk output with no effect on protein or 
fat yield (increasing the percentage), while the lactose concentration in the milk remained the 
same, supporting the theory that lactose is responsible for controlling milk volume (Holt, 1983; 
Rook & Hopwood, 1970). 
Lactose is composed of galactose and glucose subunits. In the cytoplasm, one glucose is 
converted to a UDP-galactose, and is actively transported into the golgi lumen along with 
unmodified glucose. The -lactalbumin protein is synthesized in the rough endoplasmic 
reticulum before being transported into the lumen of the golgi. In the lumen, β-1,4-
galactosyltransferase, if complexed with α-lactalbumin, forms the lactose synthase complex, and 
catalyzes the production of lactose from glucose and UDP-galactose (Kuhn, 1983). 
 While β-1,4-galactosyltransferase is found in all tissues of the body, α-lactalbumin is 
tissue specific and is only produced in the mammary gland, and only during lactation. The α-




gestation, but increases greatly during lactation in order to yield the proper conditions for high 
milk synthesis (Bell, Beyer, & Hill, 1976; Brew, Vanaman, & Hill, 1968). While the lactose 
sugar is a key regulator of milk composition and volume, α-lactalbumin is the key regulator for 
lactose synthesis, and is key for controlling milk output.  
1.6 Genome editing technology 
Genome editing is the intentional modification of the DNA of an animal to elicit a 
desired phenotype (Esvelt & Wang, 2013). The first recorded instance of the creation of 
transgenic livestock was reported in 1985, when microinjection of a 2.6kb fragment of linear 
DNA into the pronucleus or nucleus of pigs, rabbits, and sheep yielded expression of a transgene 
(Hammer et al., 1985). It is of note that in this particular study, 5000 ova were injected, yielding 
500 neonates or fetuses, 49 of which showed integration of the DNA, and 14 of which expressed 
the transgene. Since then, efficiency of integration has increased exponentially, and more 
importantly, we are able to target the location in the genome for DNA modification, as opposed 
to previous methods relying on random integration.  
While microinjection of DNA can be used to create transgenic animals by random 
integration or low-efficiency homologous recombination, programmable nucleases allow for site-
specific gene targeting at a much higher efficiency. Endonucleases can be programmed to target 
a specific area of the genome and induce a double-stranded break (Cox, Platt, & Zhang, 2015). 
Repair of these double-stranded breaks is dependent on the endogenous mechanisms of either 
non-homologous end joining (NHEJ) or homology-directed repair (HDR). NHEJ occurs when 
the cleaved ends of the double-stranded break are ligated back together without the need for a 
repair template. NHEJ is referred to as “error prone” due to its tendency to cause insertions and 




identical DNA molecule (such as the homologous chromosome) as a template for recombination, 
and is generally regarded as a faithful mechanism for recombination, provided that the template 
molecule is the same as the cleaved molecule  (Pardo, Gómez-González, & Aguilera, 2009). 
Hijacking of these endogenous repair mechanisms can lead to the knock-out (deletion), 
substitution, or insertion of DNA sequences or genes. NHEJ is used frequently to cause a 
frameshift or deletion that renders a gene unexpressed or “knocked-out,” while HDR can be used 
by supplying an exogenous repair template that contains regions of homology around the double-
stranded break.  A site-specific double-stranded break can be induced in the genome using 
programmable nucleases, such as zinc finger nucleases (ZFNs), transcription activator-like 
endonucleases (TALENs), and clustered regularly interspersed short palindromic repeats 
(CRISPRs). 
The first popular programmable endonucleases were Zinc Finger Nucleases (ZFNs). 
ZFNs are a protein comprised of a specific zinc-finger protein (comprised of approximately ~30 
amino acids), and a non-specific FokI endonuclease, which must dimerize with another FokI 
monomer in order to create an active nuclease. This requires two recognition sites which 
provides high specificity, however they are limited by the number of DNA target sites for this 
binding, and sometimes have low efficiency in cleavage (Durai et al., 2005). TALENs are similar 
to the ZFNs in that they also have a FokI endonuclease used to cleave the DNA, but they are 
instead tethered to transcription activator-like effector molecules, which are harvested from 
bacteria and can be designed to target any DNA sequence. TALENs received the Nature 
Methods “Method of the Year” in 2011 for the impact they had on science (Joung & Sander, 




 The main drawback to ZFNs and TALENs is that they are difficult to design and 
synthesize, and can take a long time to be prepared. Recently, RNA guided endonucleases have 
emerged as a popular solution, specifically with use of the CRISPR/Cas9 system.  
 CRISPRs were first discovered by Francisco Mojico in 1993 when he was working on 
characterizing enzymes in microbes and he found an unusual group of palindromic DNA repeats. 
He researched these structures and gene sequences for years and found similar sequences in other 
microbes, and eventually the acronym CRISPR evolved for the “clustered regularly interspersed 
short palindromic repeats” he had discovered (Lander, 2016; Mojica, Juez, & Rodriguez‐Valera, 
1993). CRISPR and CRISPR associated protein-9 (Cas9), were discovered to be an adaptive 
immune system in bacteria against bacteriophages. The bacteria, such as Streptococcus 
pyogenes, incorporate sequences of viral phage DNA in to their genome, and then using an 
attached RNA-protein complex, the system recognizes and cleaves matching DNA sequences 
and render the phages incompetent (Cong et al., 2013; Garneau et al., 2010). Emerging for gene 
editing purposes in 2013, the CRISPR/Cas9 system quickly became immensely popular for gene 
editing because it is relatively easy and quick to design and synthesize, and works with a high 
efficiency and specificity (Kim & Kim, 2014). CRISPRs require a 20 nucleotide target sequence 
encoded in a guide-RNA (gRNA) molecule, which must be followed by a 3 nucleotide 
protospacer adjacent motif (PAM) sequence in the target DNA (Cong et al., 2013). CRISPR 
RNAs, referred to as crRNAs, are the small spacers found in the DNA repeats that are 
transcribed into RNA to identify the complementary target site within the genome, while trans-
activating CRISPR RNAs activate the Cas9 proteins to cleave the DNA; the two were able to be 
combined to one simple guide-RNA or gRNA (Jinek et al., 2012). The CRISPR gRNA 




The CRISPR system can be introduced into cells or zygotes as plasmid DNA, mRNA, or 
protein. The plasmid DNA is transcribed and translated in the cell once introduced, while 
administered mRNA only must be translated into protein, and the protein can act directly on the 
DNA once transfected or injected. Each method has varying half-life within the cell and varying 
cutting and repair efficiencies.  
In recent and current studies, methods for gene insertion and editing are being improved 
and made more specific. Pairing a catalytically inactive (dead) Cas9 protein (dCas9) with a 
cytidine deaminase has recently emerged as a method of inducing single nucleotide edits without 
double-stranded cleavage. This system includes a dCas9, with catalytic activity restored in the 
HNH domain to allow nickase activity, a cytidine deaminase, and a uracil DNA glycosylase 
inhibitor (UGI), and is paired with gRNA as above. The dCas9 paired with the gRNA guides the 
complex to the target site, deaminates any cytosine bases within the 5-8 base pair window of the 
target sequence yielding a uracil, then induces a nick on the complementary strand, while the 
UGI inhibits the reversion of U to G. Upon repair of the nick, 15-75% of DNA is permanently 
repaired with the desired edit (Komor, Kim, Packer, Zuris, & Liu, 2016; Nishida et al., 2016). 
Subsequent studies have improved the range of PAM sequences that can be used, have increased 
the specificity of the window, and have been shown to successfully edit plants and animals in 
vivo (Y. B. Kim et al., 2017; Shimatani et al., 2017; Zong et al., 2017).  Base-editing systems 
offer distinct advantages; they have decreased off-target effects, they can safely be used without 
fear of deleterious or cancer-causing mutations, and they eliminate the need for a repair template. 
The continued development of base-editing systems such as these will be important for the repair 




Beyond traditional homology directed repair, several strategies are being employed and 
developed for the insertion of genes. These include microhomology-mediated end-joining 
(MMEJ) (McVey & Lee, 2008; Nakade et al., 2014), nuclease assisted vector integration (NAVI) 
(Brown, Woods, & Perez-Pinera, 2016), and homology independent targeted insertion (HITI) 
(Suzuki et al., 2016). Knock-ins using MMEJ involve using CRISPR or other endonucleases to 
create a double stranded break in DNA, and then supply a donor vector with short, 
microhomology (5-25 bp) on either end of an insert to induce an error-prone end-joining. HITI 
and NAVI involve using the CRISPR/Cas9 system to cut sites both at the targeted genomic DNA 
location and the donor plasmid, and use what is thought to be non-homologous end joining for 
the repair of the cut ends to insert the donor segment. These technologies have been shown to 
work in vitro and in vivo for the targeted insertion of genes, and can be developed further for 
uses in agricultural production and modern medicine to restore or augment gene functions 
without the need for a repair template or lengthy regions of homology.  
1.7 Agricultural applications for gene editing 
The aforementioned targeted gene editing systems are being employed worldwide for the 
purpose of enhancing livestock animal production. These genetic modifications can improve 
food quantity worldwide, improve animal welfare, and decrease the environmental footprint of 
livestock production. 
Genetic engineering of livestock has occurred for years to enhance production and 
introduce desirable traits.  For example, in 1989, AquAdvantage Salmon were first produced: 
Atlantic salmon harboring a growth gene from a pacific salmon under the control of a promoter 
from a fish called an ocean pout. This allows these fish to grow all year long, enabling them to 




engineered pigs to produce an increased amount of milk for increased piglet growth and survival 
by insertion of the bovine alpha-lactalbumin gene (Bleck, White, Miller, & Wheeler, 1998). In 
2005 dairy cattle were engineered to be resistant to mastitis from Staphylococcus aureus by 




a strain of 
Yorkshire pigs, were engineered in 2001 using the murine parotid secretory protein promoter and 
signal peptide to express the enzyme phytase in their saliva. The phytase enzyme allows the pigs 
to digest previously biologically unavailable phosphorus from corn, barley and other cereal 
grains, which eliminates the need for supplemental phosphorus and decreases the phosphorus 
material excreted by 60% (Forsberg et al., 2003). In 2007, scientists knocked out the gene PRNP 
encoding cellular prion protein in Holstein cattle using homologous recombination, thereby 
preventing the transmittance of Bovine Spongiform Encephalopathy (Richt et al., 2007).  
While engineered animals such as those above have been created for years, genetic 
engineering changed with the advent of targeted gene editing, which is defined as the use of site-
directed nucleases to alter DNA at a predetermined location in the genome (Van Eenennaam, 
2017). This allows us to introduce selectable traits without integrating recombinant DNA, to 
quickly integrate traits that we could select with traditional breeding selection over time, or 
simply to remove undesired genes. For example, in 2014, Ni et al used CRISPR/Cas9 to knock 
out several genes in goats; in their study, beta-lactoglobulin, a major milk allergen, was knocked 
out to decrease allergic properties of goat’s milk, prion protein was knocked out to prevent 
scrapie, a disease like BSE, and myostatin was knocked out for increased muscling (Ni et al., 
2014).  In 2015, the myostatin gene was knocked out of sheep to increase the double muscling 
phenotype for increased meat production (Crispo et al., 2015). In 2015, cattle were engineered to 




al., 2015).  In a different approach in 2016, cows were engineered to be resistant to 
Mycobacterium bovis infection by expressing the human β-defensin-3 (Su et al., 2016). In yet 
another approach in 2017, CRISPR-mediated targeted insertion of the NRAMP1 gene into the 
cattle genome was used to confer tuberculosis resistance(Gao et al., 2017). In 2015 pigs were 
engineered using CRISPR/Cas9 to be resistant to porcine reproductive and respiratory syndrome 
virus (PRRSV) by knocking out the receptor required for viral entry into cells, CD163 
(Whitworth et al., 2016).  In 2016, the POLLED allele was introduced into dairy cattle using 
TALENs and homology directed repair to eliminate the need for dehorning (Carlson et al., 
2016). In 2016, using Zinc-finger nucleases, the RELA locus of domestic pigs was edited to be 
replaced with the same gene from warthogs, conferring resistance to African Swine Fever 
(Lillico et al., 2016). 
Biopharmaceutical production is another highly popular use of transgenic animals. Using 
the above technologies, animals such as goats, cows, and pigs have been engineered to produce 
recombinant and therapeutic proteins in their milk.  Goats producing, ATryn®, human 




a C1 esterase 
inhibitor, in their milk are examples of FDA-approved biopharmaceutical products from 
transgenic animals. 
Gene editing in livestock can improve the quantity of output, quality of animal lives and 
environmental effects of farming practices. Spreading the genes for disease resistance could save 
thousands of animals and people from detrimental outbreaks. We no longer have to use years of 
breeding to select for the right combination of traits in an animal. It is even possible to edit DNA 




animals in previously unfavorable conditions and increase output of current animals, hence 
providing us with the opportunity to feed impoverished and starving regions of the world.  
1.8 Methods for gene transfer 
Using these guided endonucleases, we can make transgenic animals using several 
different methods. Some of the most popular reproductive methods for generating transgenic 
animals for gene-editing include somatic cell nuclear transfer (SCNT) of edited cells and 
pronuclear or cytoplasmic microinjection (Horii et al., 2014; Tang, González, & Dobrinski, 
2015). SCNT, also referred to as cloning, was first performed to make Dolly in 1996 (Campbell, 
McWhir, Ritchie, & Wilmut, 1996; Wilmut, Schnieke, McWhir, Kind, & Campbell, 1997). With 
this technique, it is possible to transfect somatic cells with the CRISPR/Cas9 system, verify exact 
DNA sequences with desired changes, and use those edited cells for nuclear transfer to produce 
genetically modified embryos.  Cytoplasmic microinjection involves the injection of any 
combination of CRISPR plasmid DNA, RNA, or protein encoding the information needed to 
target, knock out, correct, or insert the gene of interest directly into the cytoplasm of one-cell 
embryos, (Hai, Teng, Guo, Li, & Zhou, 2014; Horii et al., 2014). Each method has varying 
degrees of skill and difficulty associated, and different levels of success have been shown 
depending on the species for each method. 
1.9 Limitations to Gene Editing 
Approval from the Food and Drug Administration for the commercial consumption of 
AquAdvantage Salmon was requested in 1995. This approval did not come until 2016, and soon 
after approval it faced more limitations. While the FDA did not deny the request in the end, they 
essentially denied it by over twenty years of inaction, and without going to market, it is difficult 




The regulations were initially in place because of the unknown: unknown location of 
DNA integration, unknown effects of foreign genes, unknown effects of using a virus to insert 
genes that could cause cancer. Over the years we have been genetically modifying animals, we 
have shown that the risks are negligible. Furthermore, with RNA-guided endonucleases, we can 
target DNA, and make precise edits for the genetic improvement of livestock. As we uncover 
and delve deeper into the mechanisms of the genome we can take advantage of the information 
and harness it for production. The biggest limitation to this technology is public acceptance; the 
only way we can advance is if the public is willing to accept these animals as equally safe and 
nutritious as traditional animals. This is an opportunity to solve many problems of our times, if 












Chapter 2: CRISPR/Cas9 mediated repair of NHLRC2 locus in Angus 
beef cattle 
2.1 Introduction 
 In beef production, efficient growth, high quality carcass composition, and consistent 
pregnancy and calving are all important traits that have consistently been improved upon by 
genetic selection over decades. To keep up with global demands for food and meat, this upward 
trajectory must be consistently improved upon to create the most quality meat with the fewest 
resources. While nutrition and management conditions do have a significant impact, preserving 
and pushing genetic quality of production animals is vital to advance production. This is further 
demonstrated by the monetary value placed on high quality animals and their offspring to be 
used as breeding stock. 
Developmental Duplications defect (DD) is a congenital defect found in Angus beef 
cattle, and many bulls and cows of high genetic merit are carriers. Calves homozygous for this 
mutation are often born with a variety of neural tube related defects such as polymelia (the 
presence of one or more extra limbs), spina bifida, teratomas, diastematomyelia (splitting of 
spinal cord), craniofacial dysmorphogenesis, and more (Denholm et al., 2011). A genome wide 
association study determined that these defects are highly associated with a single nucleotide 
substitution in a coding region of the genome that elicits a valine to alanine change in the amino 
acid sequence.  
For a long time, gene editing technology has been used for insertion or deletion of certain 
genes. Recent developments in site-specific endonucleases present the CRISPR/Cas9 system: 




ASsociated-protein-9 (Cas9). Directed by a 20 nucleotide guide RNA (gRNA) sequence which 
binds to complementary genomic DNA that is immediately followed by a protospacer adjacent 
motif (PAM) of NGG at 3’ end, the Cas9 protein makes a double-stranded break in genomic 
DNA. This double-stranded cleavage can be repaired via non-homologous end joining or 
homology directed repair, mechanisms which can be harnessed for site specific gene editing by 
adding single stranded DNA repair templates or double stranded vectors for insertion. 
The aim of this study was to determine the potential of the CRISPR/Cas9 gene editing 
system as a tool for repairing the single nucleotide mutation associated with the DD phenotype, 
thereby restoring the DD free genotype. The long term goal is to use repaired cells taken from 
DD carriers for somatic cell nuclear transfer; in this way we can preserve and propagate animals 
of high genetic merit while making progress toward eliminating this destructive mutation from 
the population. 
 
2.2 Materials and Methods 
Cell Culture 
Bovine fetal fibroblasts were a gift from J. Beever (Dept. of Animal Sciences, UIUC). 
Fetal fibroblasts were made from Angus beef cattle and were either homozygous or heterozygous 
for the DD mutant genotype at the NHLRC2 locus.  Fetal fibroblasts were maintained in 1:1 
Dulbecco’s Modified Eagle’s Medium (DMEM) (sigma D5648): Ham’s F10 nutrient mixture, 
supplemented with 10% fetal bovine serum, 0.01µg/mL bFGF, 100 U penicillin G sodium ml
-1
, 
100 mg streptomycin sulfate ml
-1
, and 0.25 mg amphotericin B ml
-1
. Adult bovine dermal 




were removed using a scalpel, and tissue was diced into 1mm cubes and plated for one week at 
37C in DMEM supplemented with 10% fetal bovine serum, and 100 U penicillin G sodium ml
-
1
, 100 mg streptomycin sulfate ml
-1
, and 0.25 mg amphotericin B ml
-1
, until a fibroblast cell 
monolayer had been established. Both fetal and dermal fibroblasts were kept below 90% 
confluence and passaged using 0.25% Trypsin-EDTA (Fisher 25200056). 
Plasmids and Repair Templates 
Three 20 nucleotide gRNAs targeting the NHLRC2 locus within 50 base pairs of the DD 
mutation were designed according to the methods previously described (Ran et al., 2013). 
Sequences with NGG or NAG PAM site were selected according to off-target and specificity 
score, evaluated using the E-CRISP design tool (Heigwer, Kerr, & Boutros, 2014). gRNAs 
oligos were annealed to form duplexes and ligated using 5’ CACC and 5’ AAAC overhangs as 
previously described (Ran et al., 2013) into gRNA/Cas9 dual expression vectors, either 
pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid # 48138), or pSpCas9(BB)-2A-Puro 
(PX459) V2.0 (Addgene plasmid # 62988). Plasmids were a gift from Feng Zhang 
(Massachusetts Institute of Technology). Plasmids were transformed into Stellar
TM
 Competent 
Cells (Clontech); 10ng of plasmid DNA was incubated with 50 µl of competent cells for 30 min 
on ice, cells were heat shocked at 42C for exactly 60 seconds and placed back on ice for 1-2 
minutes. 500 µl of LB were added and cells were incubated by shaking at 225rpm for 1 hour at 
37C, and 100 µl were plated on LB agar plates with 100 ug/ml ampicillin. Well isolated 
colonies were selected, used to inoculate LB broth with 100 ug/ml ampicillin and shaken 
overnight at 225rpm at 37C. Plasmids were extracted using QIAGEN
®
 plasmid mini kit. gRNA 
sequence with desired insertion was verified by sequencing using the human U6 forward 




insertion site.  Custom single stranded oligonucleotide HDR templates were synthesized (IDT). 
ssODNs were 90 or 100 nucleotides with 45-50 base pairs on either side of the cut-site. 
Nucleotides in the repair template were altered at the CRIPSR binding sites to prevent re-binding 
after HDR.  
Transfections 
Cells were seeded at a 75,000 cells per well 24 hours before transfection in a 6 well plate. One 
hour before transfection, media was replaced in well to DMEM and 10% FBS with no 
antibiotics. Cells were transfected with Fugene HD according to the manufacturer’s protocol. 
1.5µg of DNA were combined with 5µl of Fugene HD in opti-MEM
TM
 reduced serum medium 
and added to each well.  24-48 hours after transfection, GFP expressing cells were sorted using 
the Fluorescence-Activated Cell Sorting BD FACS Aria II at the Flow Cytometry Facility in the 
Roy J. Carver Biotechnology Center at the University of Illinois. 5 cells per well were sorted into 
normal growth medium in 96-well plates, or 5,000 cells per well were sorted into a 6-well plate. 
At confluency, cells were passaged to larger wells and DNA was extracted for further testing.  
DNA extraction and evaluation 
For genomic DNA (gDNA) extraction, cells were washed and pelleted and resuspended in 50 µl 
of QuickExtract
TM 
(Epicentre), vortexed vigorously, incubated at 65C for 2 hours, denatured at 
95 for 10 minutes, and stored at -20C until further analysis. PCR primers were designed to 
amplify a 435 bp segment surrounding the mutation on the NHLRC2 locus. PCR was performed 
using a 25µl reaction volume composed of 100ng genomic DNA, 12.5 µl Taq JumpStart 
Readymix (Sigma P2893), 0.2 µM forward primer, 0.2 µM reverse primer, and ddH2O to 25 µl. 
The reaction was placed in the thermal cycler and subjected to 5 minutes at 95°C; 30 seconds at 




at 10°C. MWOI enzyme is a site-specific restriction endonucleases that recognizes the sequence 
containing the SNP mutation indicative of DD (GCNNNNNNNGC), and cleaves the PCR 
product if the DD mutation is present in the DNA resulting in fragments of ~330bp and ~100bp. 
1.5µl of 10x CutSmart Buffer (NEB), 0.5µl MWOI enzyme (NEB), and 8.0µl of ddH2O were 
added to 20µl of PCR product and incubated at 60C for 1 hour. Loading dye was added to each 
sample and 7µl were loaded into a 2% agarose gel containing 100ng/mL ethidium bromide. 
Samples were subject to electrophoresis at 90 Volts for 30 minutes and visualized under UV 
illumination (GelReader). For purification for sequencing or subcloning, fragments were excised 
from a 1.0% agarose gel and purified using the Monarch® Gel Extraction Kit (NEB).  
Subcloning and Sequencing 
Cells were cultured and transfected as above. 24-48 hours post transfection, 2000-5000 
fluorescent cells were sorted and pooled into one well of a 6-well plate. 3 days after the sort, 
cells were passaged with trypsin, washed, and gDNA was extracted. The NHLRC2 locus 
containing the defect was amplified using PCR as above. PCR products were cleaned-up 
QIAquick PCR Purification Kit or gel-purified and amplicons were subcloned into pGEM®-T 
Easy Vector System (Promega) according to the manufacturer’s instructions. Plasmids were 
transformed into DH5 competent cells; DH5α were stored at -80C, thawed on wet ice, 
incubated with 10 ng of plasmid for 30 minutes, heat shocked at 42C for 1 minute, placed back 
on ice for 1-2 minutes. 1 ml of LB was added and tubes were shaken for 1 hour at 37C; 200 µl 
were plated on agar plates containing 0.1mM Isopropyl thiogalactoside (IPTG), 60 µg/mL 5-
bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), and 100 µg/ml ampicillin. White 
and light blue colonies were selected using a sterile toothpick, shaken in 1 ml of LB broth with 




BAC 96 Kit (Eppendorf). To verify presence of inserted PCR product, 2µl of plasmid DNA were 
added to 2.5µl of NEB CutSmart buffer, 0.5µl EcoRI Enzyme, and ddH2O to a total reaction 
volume of 25ul. Reaction was incubated at 37C for 1 hour. Products were subjected to 
electrophoresis on 1.5% agarose gel with 100ng/ml ethidium bromide and visualized with UV 
light. Colonies containing the insert showed two bands: one >2000 bp plasmid backbone and one 
<400 bp DNA fragment excised from between EcoRI cut sites in the plasmid. 2µl of each well 
were added to 3.62 μL Sanger sequencing buffer (0.16 M Tris pH 9.0, 3.0 mM MgCl2, 4.9% 
tetramethylene sulfone and 0.001% tween 20), 0.25 μL BigDye® (Applied Biosystems), 0.08 μL 
BigDye® dGTP (Applied Biosystems), and 1.00 μM  reverse primer with a total reaction volume 
of 8.0 ul. The reaction was incubated in the thermal cycler for 90 seconds at 96C, then 54 cycles 
of 15 seconds at 96C, 15 seconds at 53C, and 3 minutes at 60C, followed by 10 minutes at 
60C and a hold at 10C. Each reaction was purified via size exclusion using Sephadex G50 in a 
25-30 MBPP Whatman Unifilter 96-well plate. After purification, the samples were sent to the 
W.M. Keck Center for Comparative and Functional Genomics for analysis and Sanger 
sequencing was provided using a 3730xl DNA Analyzer. Resulting sequences were analyzed 
using CodonCode Aligner and BioEdit Sequence Alignment Editor. 
 
2.3 Results and discussion 
The aim of this study was to determine the potential of the CRISPR/Cas9 system for the 
repair of genetic defects in cattle.  In this study, we chose to repair the single nucleotide mutation 
responsible for the developmental duplications defect in Angus beef cattle, an allele which has 




that the DD phenotype was highly correlated with a TC non synonymous substitution in the 
NHLRC2 gene on exon 5 of chromosome 26 in Bos taurus.  
Our strategy was to use the CRISPR/Cas9 complex to introduce a double stranded break 
in the DNA in the region surrounding the NHLRC2 mutation associated with DD, and then 
supply a repair template harboring the normal genotype for homology directed repair. Cas9 
complexes with a guide-RNA, which consists of a 20 nucleotide RNA sequence targeting the 
complementary genomic DNA sequence followed by the PAM, NGG.  Three, 20 nucleotide 
gRNAs were designed, all targeting genomic DNA within 50 base pairs of the mutation. These 
three sequences, with cut sites 6, 28, and 42 base pairs away from the mutation site, targeted 
DNA sequences of GATTGACCTAGAAGCTGAGA, TGGCATTGGAATTCAAGGTA and 
CAAGGTACAGATAAAGAAGG, respectively (Figure 2.1). Each of these DNA oligos (IDT 
Technologies) were cloned as a duplex into the pSpCas9(BB)-2A-GFP (PX458) (Addgene 
plasmid # 48138) plasmid encoding the gRNA scaffold and Cas9 from Streptococcus pyogenes 
(Figure 2.2).   
Transfection conditions for bovine fetal fibroblasts were optimized and found to be 6µl of 
Fugene HD combined with 2µg of DNA with 75,000 cells in a 6 well plate. Bovine fetal 
fibroblasts homozygous or heterozygous for the mutation were transfected in these conditions 
with each of these plasmids and then sorted based on fluorescence and pooled in a 6 well plate. 
Once cells recovered and reached confluence, they were analyzed using PCR and RFLP enzyme 
digest. Since the enzyme MWOI recognizes the exact sequence with the mutation present 
(GCNNNNNNNGC), any disruption in the sequence prevents enzyme cleavage, whether it is the 
repaired genotype or an indel (Figure 2.3). GelAnalyzer analysis of the cleavage frequency 




13.3% and 12.2% efficiency in cells heterozygous and homozygous for the mutation, 
respectively, while gRNA 3 disrupted the mutation site at 2.5% and 4.1% for homozygous and 
heterozygous cells, respectively (Figure 2.4). Minimal differences from the control were seen 
with gRNA 3 because it was 42 base pairs away from the cleavage site—not close enough to 
show any difference. Because gRNA 1 successfully targeted the optimal cut site at 6 base pairs 
away from the mutation, cleavage efficiency was not calculated for gRNA 2. For the remainder 
of the experiment, gRNA 1 was used. 
To further verify the cleavage at the NHLRC2 locus, the PCR products were amplified 
and subcloned into pGEM®-T Easy Vector System (Promega), and subsequently sequenced. The 
sequence results support the enzyme cleavage data, showing that 16 sequences out of 76 had 
indels at the Cas9 cut-site, approximately 21.1%. The majority of the sequences showed 
deletions, with a few insertions (Figure 2.5). Once we knew the CRISPR was effectively cutting 
at the desired locus, we then designed a single stranded oligonucleotide (ssODN) repair template 
to supply for homology directed repair. This ssODN harbored the DD free “T” genotype to 
replace the C allele found in the mutant cells. Furthermore it contained a silent substitution 
mutation in the gRNA sequence to prevent CRISPR binding to the repaired genotype (Figure 
2.6).  Sequencing results from cells transfected with this system showed that 5 out of 60 
sequences were correctly repaired, and that the repair efficiency is approximately 8.3% of edited 
cells (Figure 2.8). 
From these data, we can conclude that the CRISPR/Cas9 system can successfully be used 
for the repair of congenital defects in cattle. To our knowledge, this represents the first time that 
this technology has been shown to be used for repair of congenital defects in cattle. To prove that 




generating a clone using the repaired genetic material from a homozygous recessive calf with 
phenotypic manifestations of DD. Nevertheless, the neural tube defects and possible embryonic 
loss associated with the homozygous recessive inheritance of the DD allele greatly decrease the 
value of these animals, and represent a great cost to the beef industry. Carriers of the defect are 
unaffected, so it was not until the carrier frequency was 6% in the US and 14% in Australia that 
the mutation was researched fully. The economic impacts of the relatively high frequency of this 
mutation are yet to be fully understood, especially because it is likely that the recessive 
homozygotes are embryonically lethal. However, to remove high quality bulls and cows that are 
carriers for this mutation from the population entirely would a) incur heavy costs against farmers 
who invested in these animals, and b) would remove beneficial alleles and quality genetics from 
the population along with this destructive allele. Providing a method to “fix” these cows and 
their progeny can resolve these problems. 
Cloning is already a common practice among public and private farms. The FDA has 
declared meat and milk from cloned cows, goats and swine is as safe to eat as that of sexually 
produced offspring.  Repairing the genetic defect would use the same procedures as cloning with 
the addition of a quick gene editing step to ensure the animal is no longer a carrier for the defect. 
Cells would be taken from the animal of interest, cultured, repaired and fully sequenced, and 
then cloned and grown just as any other cloned animals. This system could be used not only for 
DD in cattle, but also for a wide panel of genetic defects in livestock species. Gene editing paired 
with cloning allows farmers to promote the superior genetics of their high performing livestock 
while simultaneously restricting the propagation of destructive alleles. In this way, we can 
continue to advance the genetic quality of livestock to improve production quantity and maintain 








Figure 2.1: Guide RNA target sequences on the NHLRC2 gene in Angus cattle. gRNA 1 (red), 
gRNA 2 (blue), and gRNA3 (green) all are followed by a PAM sequence of NGG or NAG. The 
















Figure 2.3: RFLP enzyme digests of the NHLRC2  PCR products using enzyme MWOI. Lane 1) 
ladder, 2) empty, 3 and 4) Angus DNA heterozygous for the DD-associated mutation, 5 and 6) 
Angus DNA homozygous for the mutation, 7 and 8) Angus DNA homozygous normal without 








Figure 2.4: RFLP digests of PCR products using enzyme MWOI. Lanes 2-7 are amplified from 
DNA from Angus fetal fibroblasts with the indicated genotype, (Ho indicates homozygous for 
the DD associated SNP, Hz indicates heterozygous). Lanes 4-7 are pooled cell extractions, all 
transfected with the CRISPR/Cas9 plasmid from figure 2.2. Note that gRNA 1 shows noticeable 
difference in cleavage for both homozygous and heterozygous cells, indicating that the enzyme 
















Figure 2.5: DNA sequences from heterozygous and homozygous Angus fetal fibroblast cells, 
transfected with the gRNA1 CRISPR/Cas9 plasmid, sorted and pooled. The red arrow indicates 
the location of the DD associated SNP. Various indels can be observed at the cleavage site 









Figure 2.6: Sequence of the 90 nucleotide ssODN repair template transfected with the 
CRISPR/Cas9 plasmid. The red box labeled “1” indicates the position for the DD mutation, 
restored to the wildtype “T.” The red box labeled “2” indicates the silent mutation inserted to 














Figure 2.7: RFLP analysis with enzyme MWOI. Lane 1) ladder, 2) homozygous DD mutation 
control, 3-8) Pooled, sorted cells transfected with gRNA1 CRISPR/Cas9 plasmid and the ssODN 
















Figure 2.8: DNA sequences from edited cells transfected with gRNA1 CRISPR/Cas9 plasmid 
and the ssODN repair template. Uncleaved fragment from digestion in figure 2.7 was gel-
excised, subcloned, and sequenced. Black arrow indicates site for DD associated SNP; “T” at 







Chapter 3: CRISPR/Cas9 mediated editing of the α-lactalbumin locus in 
Nelore dairy cattle 
3.1 Introduction 
With the global population expected to reach 9 billion people by 2050, we must produce 
100% more food in the next thirty years to prevent a hunger epidemic worldwide (Simmons, 
2011). We have worked for years to optimize production of crops, meat and dairy. The goal is 
simple: make more products with fewer resources. With great thanks to modern reproduction 
methods for improved genetics, milk production per animal has more than doubled in the past 
forty years. In dairy cattle, several studies (Bleck & Bremel, 1993a, 1993b; Martins et al., 2008; 
Mir et al., 2014) have shown a correlation between a single-nucleotide polymorphism in the 
alpha-lactalbumin 5’ untranslated region at (+15) base pairs from the transcriptional start site and 
increased milk yield. This mutation is a guanine to adenine substitution in the non-coding region 
of the mRNA, and has been shown to be associated with increased milk yield in both Holstein 
and Nelore cattle, likely due to increasing the binding affinity of transcription factors. Since it 
originated in Holstein, the (+15) adenine allele is found at a high frequency among the Holstein 
population, but a very low frequency in the Nelore population and is achieved through cross-
breeding.   
The clustered regularly interspersed short palindromic repeats (CRISPR)/Cas9 system 
has been shown in recent years to be an effective tool for targeted gene editing (Cong et al., 
2013; Lillico et al., 2016; Ran et al., 2013). The CRISPR/Cas9 protein is paired with a guide-
RNA, which is an RNA loop that can be programmed to target any specific 20 nucleotide 




(Jinek et al., 2012). The gRNA complexes with the Cas9 protein to induce a double stranded 
break in the three nucleotides upstream of the protospacer adjacent motif (PAM) sequence. 
Mammalian cellular repair systems employ one of two mechanisms to mend these breaks: non-
homologous end joining (NHEJ) or homology directed repair (HDR). By supplying an 
exogenous, single strand oligonucleotide (ssODN) repair template that has homology to the cut 
site, desired changes can be inserted at the target locus.  
The goal of this study was to examine the potential for the CRISPR/Cas9 system to be 
used to edit the alpha-lactalbumin gene in Nelore cattle cells. The long term goal of this study is 
to use this technology for the targeted substitution of the adenine allele for the guanine allele in 
the alpha-lactalbumin promoter region, and use gene-edited fibroblasts for somatic cell nuclear 
transfer to create tropically adapted cattle with increased milk yield. 
 
3.2 Materials and Methods 
Cell Culture 
Dermal fibroblast cells were a gift from C. Long (College of Veterinary Medicine & Biomedical 
Sciences, Texas A&M University). Fibroblasts were isolated from skin of Nelore heifers. Cells 
were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) (sigma D5648) 
supplemented with 10% fetal bovine serum, 100 U penicillin G sodium ml
-1
, 100 mg 
streptomycin sulfate ml
-1
, and 0.25 mg amphotericin B ml
-1
 Dermal fibroblasts were kept below 




Plasmids and Repair Templates 
A gRNA targeting the LALBA locus with a cut site 5 base pairs from the desired mutation site 
were designed according to the methods previously described (Ran et al., 2013). The 20 
nucleotide sequence GTGACCCCATTTCAGAATCT followed by the PAM sequence of TGG 
was designed as the gRNA target. DNAs oligos (IDT Technologies) 
5’CACCGTGACCCCATTTCAGAATCT 3’and 5’AAACAGATTCTGAAATGGGGTCAC3’ 
were annealed to form duplexes and ligated into CRISPR plasmids using 5’ CACC and 5’ 
AAAC overhangs as previously described (Ran et al., 2013) into gRNA/Cas9 dual expression 
vectors, either pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid # 48138), or pSpCas9(BB)-
2A-Puro (PX459) V2.0 (Addgene plasmid # 62988). Plasmids were a gift from Feng Zhang 
(Massachusetts Institute of Technology). Plasmids were transformed into Stellar
TM
 Competent 
Cells (Clontech); 10ng of plasmid DNA was incubated with 50 µl of competent cells for 30 min 
on ice, cells were heat shocked at 42C for exactly 60 seconds and placed back on ice for 1-2 
minutes. 500 µl of LB were added and cells were incubated by shaking at 225rpm for 1 hour at 
37C, and 100 µl were plated on LB agar plates with 100 ug/ml ampicillin. Well isolated 
colonies were selected, used to inoculate LB broth with 100 ug/ml ampicillin and shaken 
overnight at 225rpm at 37C. Plasmids were extracted using QIAGEN
®
 plasmid mini kit. gRNA 
sequence with desired insertion was verified by sequencing using the human U6 forward 
promoter primer (LKO.1 5'GACTATCATATGCTTACCGT (Weinberg Lab)) to amplify the 
insertion site.  Custom single stranded oligonucleotide HDR templates were synthesized (IDT). 





For selection based on fluorescence, cells were seeded at 75,000 cells per well 24 hours before 
transfection in a 6 well plate. One hour before transfection, media was replaced in wells with 
DMEM and 10% FBS with no antibiotics. Cells were transfected with Fugene HD according to 
the manufacturer’s protocol. 1.5µg of DNA were combined with 4.5µl of Fugene HD in opti-
MEM
TM
 reduced serum medium and added to each well. Transfection reagent media was 
removed 24 hours later, and 24-48 hours after transfection, GFP expressing cells were sorted 
using the Fluorescence-Activated Cell Sorting BD FACS Aria II at the Flow Cytometry Facility 
in the Roy J. Carver Biotechnology Center at the University of Illinois. Five cells per well were 
sorted into normal growth medium in 96-well plates or 5,000 cells per well were sorted into 6-
well plates. At confluency, cells were passaged to larger wells and DNA was extracted for 
further testing.  
For selection based on puromycin, cells were seeded at 10,000 cell/well in a 24 well plate. A 
puromycin kill curve was performed for Nelore dermal fibroblasts; 1µg puromycin/ml media 
was determined to be the proper concentration for efficient selection. For transfection, 500ng of 
plasmid and 500ng of repair template in addition to 100ng of a puromycin resistance plasmid 
were added with 1.5µl Fugene HD per well. Cells were transfected as above. 24 hrs following 
transfection, media was replaced with normal growth medium. 48 hrs post transfection, cells 
were passaged, and 2 wells from a 24 well plate were combined to one 6 well plate containing 1 
ug/ml  puromycin. Media containing antibiotics was changed every other day for 5 days. After 




DNA extraction and evaluation 
For genomic DNA (gDNA) extraction, cells were washed and pelleted and resuspended in 50 µl 
of QuickExtract
TM 
(Epicentre), vortexed vigorously, incubated at 65C for 2 hours, denatured at 
95 for 10 minutes, and stored at -20C until further analysis. PCR primers were designed to 
amplify a 443 bp segment surrounding the mutation at the LALBA locus, amplifying the region   
(-363) to (+80) relative to the transcriptional start site. PCR was performed using a 25µl reaction 
volume composed of 100ng genomic DNA, 12.5 µl Taq JumpStart Readymix (Sigma P2893), 
0.2 µM forward primer, 0.2 µM reverse primer, and ddH2O to 25ul. The reaction was placed in 
the thermal cycler and subjected to 5 minutes at 95°C; 30 seconds at 94°C, 30 seconds at 56°C 
and 30 seconds at 72°C for 30 cycles; 15 minutes at 72°C, and 5 min at 10°C.  
PCR products were then subjected to a T7 endonuclease assay (NEB) to determine cleavage. 
After amplification in the thermal cycler, products were annealed in the thermal cycler with an 
initial denaturation at 95°C for 5 minutes, ramped to 85°C at -2°C/second, then ramped to 25°C 
at -0.1°C/second, followed by hold at 4°C. 20µl of unpurified PCR annealed products were 
added to 0.5µl T7 endonuclease and 5µl NEB buffer 2 for a 50µl reaction volume and incubated 
at 37°C for 30 minutes. 2 µl of 0.5M EDTA was added to stop the reaction. 10µl were subject to 
gel electrophoresis on a 2% agarose gel containing 100ng/mL ethidium bromide and visualized 
under UV light.  
PCR products were also subjected to restriction fragment length polymorphism (RFLP) analysis 
with a site specific restriction endonuclease. BpuEI enzyme is a site-specific endonucleases that 
recognizes the sequence containing the (+15) α-lactalbumin mutation (CTTGAG), and cleaves 
the PCR product if the mutation is present in the DNA. 1.5µl of 10x CutSmart Buffer (NEB), 




incubated at 60C for 1 hour. Loading dye was added to each sample and 7µl were loaded into a 
2% agarose gel containing 100ng/mL ethidium bromide. Samples were subject to electrophoresis 
at 90 Volts for 30 minutes and visualized under UV illumination (GelReader).   
Colony Isolation 
After transfection with GFP indicator and sorting by flow cytometry cells were seeded at low 
density (1000 cells/100mm diameter dish) in normal growth medium. After transfection with 
puromycin resistance plasmid, one well from a 24 well plate was passaged and seeded into a 
100mm diameter plate in normal growth medium supplemented with 1ug/ml of puromycin, and 
subjected to antibiotic selection for 5 days. For both methods, after approximately 7-10 days 
tight colonies were visible in a microscope and marked on the underside of the plate. After media 
removal and rinsing with Dulbecco’s phosphate buffered saline (PBS), cloning cylinders were 
placed on the marked colonies using jeweler’s forceps. 1ml of 1% low melting point agarose 
heated and dissolved in PBS was pipetted around the cylinders and allowed to cool slightly 
before 40µl of trypsin was added on top of each colony within the cylinder as described 
(Mathupala & Sloan, 2009). After 3-5 minutes, the trypsinized colonies were transferred to a 24 
well plate where they were cultured in normal growth medium and allowed to reach confluence 
before analysis.  
Subcloning and Sequencing 
Cells were cultured and transfected as above. 24-48 hours post transfection, 2000-5000 
fluorescent cells were sorted and pooled into one well of a 6-well plate. 3 days after the sort, 
cells were passaged with trypsin, washed, and gDNA was extracted. The LALBA locus 
containing the defect was amplified using PCR as above. PCR products were cleaned-up 




Easy Vector System (Promega) according to the manufacturer’s instructions. Plasmids were 
transformed into DH5 competent cells; DH5α were stored at -80C, thawed on wet ice, 
incubated with 10 ng of plasmid for 30 minutes, heat shocked at 42C for 1 minute, placed back 
on ice for 1-2 minutes. 1 ml of LB was added and tubes were placed on shaker for 1 hour at 
37C; 200 µl was plated on agar plates containing 0.1mM Isopropyl thiogalactoside (IPTG), 
60ug/mL 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), and 100 µg/ml 
ampicillin. White and light blue colonies were selected using a sterile toothpick, shaken in 1ml 
of LB broth with 100 ug/ml ampicillin at 37C for 20 hours overnight. Plasmids were extracted 
using PerfectPrep BAC 96 Kit (Eppendorf). To verify presence of inserted PCR product, 2µl of 
plasmid DNA were added to 2.5µl of NEB CutSmart buffer, 0.5µl EcoRI Enzyme, and ddH2O 
to a total reaction volume of 25ul. Reaction was incubated at 37C for 1 hour. Products were 
subjected to electrophoresis on 1.5% agarose gel with 100ng/ml ethidium bromide and visualized 
with UV light. Colonies containing the insert showed two bands: one >2000 bp plasmid 
backbone and one <400 bp DNA fragment excised from between EcoRI cut sites in the plasmid. 
2µl of each well were added to 3.62 μL Sanger sequencing buffer (0.16 M Tris pH 9.0, 3.0 mM 
MgCl2, 4.9% tetramethylene sulfone and 0.001% tween 20), 0.25 μL BigDye® (Applied 
Biosystems), 0.08 μL BigDye® dGTP (Applied Biosystems), and 1.00 μM  reverse primer with a 
total reaction volume of 8.0 ul. The reaction was incubated in the thermal cycler for 90 seconds 
at 96C, then 54 cycles of 15 seconds at 96C, 15 seconds at 53C, and 3 minutes at 60C, 
followed by 10 minutes at 60C and a hold at 10C. Each reaction was purified via size 
exclusion using Sephadex G50 in a 25-30 MBPP Whatman Unifilter 96-well plate. After 
purification, the samples were sent to the W.M. Keck Center for Comparative and Functional 




Resulting sequences were analyzed using CodonCode Aligner and BioEdit Sequence Alignment 
Editor. 
3.3 Results and discussion 
The aim of this study was to determine the potential of the CRISPR/Cas9 system for the 
introduction of a single base substitution in cattle. A GA substitution at the (+15) position 3’ 
from the α-lactalbumin (LALBA) transcriptional start site was selected as a target for editing 
because it is a mutation found naturally in Holstein cattle and is associated with increased milk 
yield (Bleck & Bremel, 1993a). At that locus, (+15) mutation (A allele) is theorized to increase 
the affinity of transcription factors for the α-lactalbumin milk protein, which is upregulated and 
in turn increases the production of lactose, the major osmole regulator in milk, and therefore 
increases milk volume (Brew et al., 1968). This mutation, is shown to be significantly correlated 
with increased milk yield (P<0.05 for homozygotes and P=0.07 in heterozygotes) in both 
Holstein and Nelore cattle  (Bleck & Bremel, 1993a; Mir et al., 2014). The CRISPR/Cas9 
targeted endonuclease system provides an opportunity to introduce this mutation into tropically 
adapted dairy cattle for increased milk yield. 
Here, we present a strategy for seamless substitution of the A allele at the LALBA (+15) 
locus in Nelore DNA. The CRISPR/Cas9 system is composed of Cas9 protein, which induces a 
double stranded break in the DNA, and a gRNA scaffold, which complexes to guide the protein 
to the cut site. In this study we used the pSpCas9(BB)-2A-GFP (PX458) (Addgene plasmid # 
48138) plasmid to encode Cas9 and our gRNA scaffold, and cloned the 20 nucleotide target 
sequence 5’GTGACCCCATTTCAGAATCT 3’ into the scaffold backbone (Figure 3.1). This 
gRNA sequence binds to the (-8)to(+12) bases relative to the LALBA transcriptional start site, 




directed repair, a ssODN of 90 nucleotides with 45bp homology arms on either side of the target 
site harboring the +15 single base substitution was supplied with the CRISPR/Cas9 system. In 
other studies, silent mutations are frequently added to prevent the rebinding and recutting of 
repaired DNA. In this system, since the target site is not a coding region and the effects of 
additional mutations would be unknown, the gRNA was designed so that the 3nt PAM sequence 
following the gRNA target sequence (NGG) would be altered by the GA +15 mutation (to 
NGA), and thereby seamlessly prevents rebinding of repaired loci (Figure 3.3). 
Dermal fibroblasts from Nelore cows lacking the mutation were used in the transfection. 
Preliminary experiments optimizing transfection conditions showed that using Fugene HD at a 
4.5ul:1µg DNA ratio in transfection conditions is optimal with minimal cell death, at a cell 
concentration of 10,000 cells/24 well plate (5250cells/cm
2
). The px458 plasmid encodes the GFP 
protein as a transfection indicator. While transfection with only the GFP plasmid or only the 
CRISPR-GFP plasmid yielded transfection greater than 30% in adult dermal fibroblasts, the 
transfection efficiency as shown by GFP expression in flow cytometry was decreased to less than 
1% of living cells when repair template was added. The amount of DNA was kept constant, and 
the amount of CRISPR plasmid was decreased as repair template ssODN was added. Due to low 
survival after flow cytometry, a puromycin resistance plasmid was added as a less stressful 
option, and a kill curve was calculated. The optimal concentration of puromycin for selection of 
Nelore dermal fibroblasts was found to be 1µg puromycin/mL of media. After puromycin 
selection, wells were grown to confluency and DNA was extracted from the pooled collection of 
transfected cells.  
DNA from pooled, transfected Nelore was amplified using primers for the LALBA 




at the +15 locus (Figure 3). Pooled DNA was sent to sequencing and analyzed for decomposition 
to further verify cleavage at this locus using TIDE, and showed a 26.8% cleavage efficiency at 
the target locus (Brinkman, Chen, Amendola, & van Steensel, 2014) (Figure 3.5). The pooled 
PCR products were then subjected to a restriction fragment length polymorphism digest using 
the BpuEI enzyme to determine whether the “A” allele was inserted at the (+15) position in the 
LALBA gene. Because the BpuEI enzyme does not completely digest even the positive control, it 
is not possible to accurately predict the cleavage efficiency using PCR and RFLP alone. 
Sequencing of the pooled PCR product confirmed that there was cleavage at that site (Figure 
3.6). While there is a slight band visible from the pooled, transfected Nelore, the cleaved band 
does not align with the positive control band. These results show that this system successfully 
creates a double-stranded break 6 base pairs upstream of the (+15) site of the LALBA gene. 
Further studies must be done to verify proper insertion of the A allele.   
Dairy producers in temperate climates such as the United States have done a very good 
job optimizing milk yield, with Holsteins now producing on average 23,000 pounds of milk per 
animal per lactation (HolsteinAssociationUSA, 2017). The majority of this increase yield has 
been dependent on genetic selection and the advent of artificial reproductive technologies, such 
as artificial insemination and embryo transfer, in addition to improved nutrition and health status 
of the animals. Cows now produce on average double the amount of milk that they did forty 
years ago; it now requires 90% less land and 65% less water to make one gallon of milk than it 
did in 1944 (Simmons, 2011).  This amount of milk is sufficient to distribute of milk, butter, 
cheese and other dairy products throughout the US,  in addition to the export market growing 
yearly, with $5.3 billion of dairy products exported in 2015 (Newton, 2016). Nevertheless, it is 




from malnourishment (Godfray et al., 2010). Unlike the average of 9 gallons in the US, the 
global average for milk production is 2 gallons per day (HolsteinAssociationUSA, 2017).  
Improving the output and efficiency globally by just 4.75 oz per cow per day per year is 
estimated to be sufficient to fill the current demand for milk (Elanco, 2017), and that number 
must increase with population growth.  
The greatest room for growth lies within the poorest producing countries. These tropical 
climates are too severe for Holsteins, which have been shown to produce poorly and die in the 
heat and without enough resources to meet their demands (Marshall, 2014). In developing 
countries, “high output—high input” breeds like Holsteins are generally not successful due to 
high mortality and morbidity in attempted low-management conditions (Marshall, 2014). Many 
famers in poor or rural conditions must choose between the “high output—high input” and the 
“low output—low input” animals. The low input cattle are usually hardy and survive well in the 
event of dry years, too much rain or extremely hot temperatures, but production output is limited. 
Conversely, the high input cattle are vulnerable and stressed in tropical climates and susceptible 
to diseases (Marshall, 2014). Crossbred cattle have been explored as a solution to this problem, 
but production traits or adaptive traits are often compromised. The solution to this problem 
seems clear: create an animal that is entirely tropically adapted but that has capacity for 
increased yield in years with good conditions. 
Milk yield volume has been shown to depend upon lactose as the major osmole-regulator 
in synthesis, which in turn is regulated by the alpha-lactalbumin protein concentration. A DNA 
mutation in the promoter region for the alpha-lactalbumin gene that increases the amount of 
alpha-lactalbumin expressed has been shown to be correlated with an increase in milk yield in 




lactose synthesis, which in turn draws in water and drives production. Studies have shown that a 
short term insulin infusion (decreasing blood glucose availability, therefore limiting a key 
substrate for lactose synthesis) was shown to decrease milk output with no effect on protein or 
fat quantity, while the lactose concentration in the milk remained the same, despite decreased 
volume, supporting the theory that lactose is responsible for controlling milk yield (Holt, 1983; 
Rook & Hopwood, 1970). This study also suggests that cows with this mutation are responsive 
to changes in intake, meaning that in stressful or dry years, tropically adapted cows such as 
Nelore with this mutation would still survive well and produce reasonable quantities. But given 
better nutrition, research suggests that they will out-produce their wildtype counterparts.  
In this study, we showed how the CRISPR/Cas9 system could be used in bovine cells for 
a targeted, single-base substitution as a means to improve genetic yield. Cells with this 
substitution would harbor a scarless substitution that in theory could be achieved over years 
through reproductive selection, for example by crossing Nelore and Holstein cattle. If 
reproduction was used, the crosses would contain alleles from both parents, thereby increasing 
the milk yield, but also decreasing the tropical adaptivity and giving up some traits essential for 
production success. By using gene editing, we are able to change one or a few traits, while 
leaving the majority of the genetics unchanged.  The ability to choose exactly what alleles are 
expressed in offspring provides an invaluable opportunity for livestock production. 
Our long term goal for this study is to use Nelore fibroblasts that harbor homozygous A 
alleles at the (+15) LALBA site for somatic cell nuclear transfer. Further single-cell sequencing 
must be done to confirm the substitution at this locus, and to check for any off-target mutations 
created by this data. Milk yield data from these cows compared with their non-edited 




increased milk yield, and furthermore determine the value that the addition of this trait would 
have. While the efficacy of this edit is being proved with the cloned heifers, the next step would 
be to create a homozygous Nelore bull to propagate the dissemination of the desired genotype on 
a larger scale to make this mutation occur at a high frequency in the Nelore breed, such as it is in 
Holstein. Supplementing native genetics with natural mutations such as this one will help us 








Figure 3.1: Map of the CRISPR/Cas9 plasmid. BOVLACTALB indicates the gRNA 20 
nucleotide sequences, ligated into the plasmid adjacent to the sequence for the rest of the gRNA 






Figure 3.2: Genome sequence at BALB locus in the Bos indicus genome, chromosome 5 (NCBI 
Gene ID:109558698). Red box labeled “gRNA” indicates CRISPR recognition site. Blue line 
labeled “cut-site” indicates site for double-stranded cleavage by Cas9. The (+15) site is also 












Figure 3.3: Sequence of the repair template supplied with the CRISPR/Cas9 plasmid. Red box 
indicates the single base pair substitution at the (+15) site. Repair with this template changes the 






Figure 3.4: T7 Endonuclease assay on Nelore cells. Lane: 1) ladder, 2) pooled puromycin 
selected pooled Nelore cells, transfected with plasmid and repair template, 3) pooled GFP sorted 
Nelore cells, transfected with plasmid and template, 4) non-transfected cells, 5) pooled GFP 
sorted cells, transfected with plasmid and template, 6) isolated Nelore colony, transfected with 
CRIPSR plasmid and repair template, 7) non-transfected Nelore cells. Lanes 2, 3, 5, and 6 show 




























Figure 3.5: Chromatograms from sequences of A) non-transfected Nelore DNA and B) pooled, 
transfected Nelore DNA. Sequences are consistent and uniform until the CRISPR cut-site (black 
arrow), and then multiple bases are present at any given position. C) TIDE: Tracking of Indels by 
DEcomposition (Brinkman et al., 2014) analysis of sequences from A) and B). Analysis indicates 







Figure 3.6: BpueI enzyme digest of Nelore cell DNA LALBA PCR product. Lane 1) non-
transfected Nelore fibroblast DNA 2) Holstein DNA heterozygous for (+15) mutation, control 3) 
pooled, transfected Nelore cells 4) isolated transfected Nelore colony. Lane 3 shows cleavage 




Chapter 4: General Discussion 
 Humans have been shaping and selecting the genetics of domestic animals for thousands 
of years. Breeding domesticated animals to promote certain traits has resulted in the emergence 
of additional breeds and a great deal of variation in production animals around the world. The 
speed of genetic selection has increased significantly with the advent of artificial reproductive 
technologies (ART), which allow us, for example, to take semen from bulls in Canada and mix 
them with eggs from cows in Brazil, and transfer the resulting embryos to recipients in Kenya. 
Breeding is now a global phenomenon.  
 The entire bovine genome was first sequenced in 2009 (Elsik, Tellam, & Worley, 2009). 
Since then, developments in bioinformatics and genetic markers now allow us to select animals 
as breeding stock based on genetic merit before they are even born. The pace of selection is still 
accelerating, which is extremely necessary given the demands of the exponential population 
growth. The next step to continue the necessary advances in production is the incorporation of 
gene editing. 
 Initially, gene editing was dependent on low-efficiency homologous recombination, viral 
transduction, and random integration, and has existed for years. Using this technology, we have 
gathered knowledge about the role of genes and gene networks, but were limited by low 
efficiency and little control over where genes were changed. That was, until site specific 
endonucleases were harnessed as a tool to create targeted breaks in the DNA which can be 
repaired with strategic methods.  
The studies performed in Chapter 2 and Chapter 3 demonstrate the capability of the 




the improvement of genetic merit and production performance. The majority of studies using 
CRISPR/Cas9 and other RGENs in livestock have involved knocking out genes, such as 
myostatin (Crispo et al., 2015; Ni et al., 2014) or prion proteins (Richt et al., 2007), but fewer 
studies have demonstrated the insertion of genes, and even fewer have demonstrated single 
nucleotide substitutions in livestock species.  
Though we have been changing the livestock genome for years, regulations still prohibit 
the majority of animals that have been modified using RNA guided endonucleases from being 
sold in the market. Regulations are necessary to prevent reckless or inhumane engineering of 
animals. However, in the case of the Aquabounty AquAdvantage salmon, it took more than 20 
years for a thoroughly proven safe product to be allowed to reach the markets in the US. A more 
efficient, comprehensive legal system must be developed for the regulation of transgenic 
animals. Until then, the genetically repaired Angus cattle and enhanced LALBA Nelore cattle 
derived from this study cannot be used in production.   
Beyond the CRISPR/Cas9 system demonstrated in these experiments, other versions of 
CRISPRs exist and are being used today. This commonly used CRISPR/Cas9 from 
Streptococcus pyogenes is predicted to be one of thousands similar to it. For example, the Cas9 
orthologue found in Staphylococcus aureus is 1kb smaller and has similar targeting efficiency 
(Ran et al., 2015), and therefore can more efficiently be packaged in adeno-associated viruses or 
other methods for gene delivery. Our gene editing toolbox is constantly being expanded and 
improved. This is especially true as more and more endogenous cellular machinery is understood 
well enough to harness for our use. For example, the cytidine deaminase and uracil glycosylase, 
both enzymes found naturally in cells, have now been reconfigured to work together combined 




making double stranded DNA breaks. Termed “base editing” technology, these systems present 
distinct advantages over the Cas9 used in this research, as the lack of double stranded DNA 
breakage decreases the possibility of indels, off-target cleavage, and uncontrolled mutation. In 
future studies, we would like to explore the potential of these base editors in cattle to repair 
genetic defects or create single base substitutions that we have shown in this study (see 
appendix). Microinjection of base editor proteins and gRNAs into oocytes and embryos could be 
preferable to the systems described in Chapters 2 and 3.  
 It is probable that in the future will have such grasp on the genetic code that we can write 
our own genes. However the complexity of that skill is beyond any tangible goal at the moment. 
Collective efforts are being employed both on the development side of gene editors and on 
delivery methods. Great progress has allowed for these systems to be employed in vitro and in 
vivo, for agricultural, biomedical and basic science purposes all around. As this continues to 
develop, and traits like DD are removed and traits like the (+15) A allele are incorporated, it will 
be important to look at the big picture for implementing gene editing in agriculture on a larger 
scale. As discussed, limitations to livestock output are specific to the conditions in each 
production environment around the world. Studies are continuously being published 
demonstrating the benefits of different traits being added or knocked out of any given species. 
But ideally, to maximize our global agricultural output, we will collectively establish the optimal 
traits for each livestock species for each global region, and then we will design and produce a 
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Appendix A: Additional Figures 
 
Figure A.1: Transfection optimization of dermal fibroblasts using GFP plasmid and Fugene HD 



















































Figure A.3:  RFLP using enzyme BpueI of PCR products extracted from single-cell Nelore 
colonies transfected with the CRISPR/Cas9 plasmid and sorted. Further examination showed that 









Appendix B: Protocols for Transfections and Analysis 
B.1 Transfection of Bovine Fetal Fibroblasts with FuGENE HD 
1) Seed cells 24 hrs before transfection at 75,000 cells/well in 6 well plate (15,000 in a 24 
well plate) in normal growth medium. 
2) 1 hr before transfection change media to growth media without antibiotics. 
3) Using  a 3 µl FuGENE: 1ug DNA ratio (optimized based on cell type), calculate the 
amount of each reagent needed.  




FuGENE HD 12µl 
Plasmid DNA 4 µg 
 
4) Add FuGENE HD to tube with Opti-MEMTM reduced serum medium. 
5) Add plasmid DNA to Opti-MEMTM and FuGENE tube. 
6) Vortex gently and centrifuge briefly. Incubate at room temperature for 15 min. 
7) Add 150µl of the tube to each well. 
8) Return plate to the growth incubator for 24 hrs.  
9) After 24 hrs, remove transfection media and replace with normal growth media 
(including antibiotics). 
10) Examine UV fluorescence under microscope to estimate transfection efficiency if 







B.2 Preparation of Transfected Cells for Fluorescence Activated Cell Sorting 
 
1) 24-48 hours after transfection with a fluorescent protein, estimate transfection efficiency 
with fluorescent microscope. 
2) Trypsinize each well according to cell culture protocols as normal: rinse with PBS, add 
trypsin, allow for cells to detach, then add equal part DMEM.  
3) Combine all wells transfected with the same plasmid, centrifuge at 1000 x g for 5 
minutes. Resuspend pellet in normal DMEM (with antibiotic) at 1 million cells/mL. 
4) Determine whether cells will be sorted into 6-well, 24-well, 96-well plates or a tube. Fill 
the desired plates with an appropriate amount of media.  
5) Bring samples to FACS facility. Be sure to bring a non-transfected control sample to 
establish parameters for each cell type.  
6) Transfer samples to tubes compatible with FACS machine. Add propidium iodide 
(2µl/ml media) to sample to stain dead cells. *Be sure that transfection reagent has been 
removed for at least 24 hrs to prevent propidium iodide from staining live cells. Do not 
use propidium iodide if transfection reagent has not been removed for over 24 hrs.  
7) Sort samples into plates. For 96 well plates, sort 3-5 cells per well and centrifuge plates 
briefly to help cells attach to bottom. For sensitive cells, 25% conditioned media can be 
used to improve survival.  
8) Allow cells to grow to confluency before passaging to larger well or extracting DNA for 































B.3 Quick DNA extraction from Cells 
 
1) Harvest cells from plates and centrifuge at 1000 xG for 5 min to pellet. Resuspend in 
PBS to wash, transfer to 0.5ml PCR tube, and then centrifuge again to pellet.  
2) Add approximately 100 µl of QuickExtractTM per million cells (lower volume can be used 
for fewer cells).  
3) Vortex to resuspend pellet and centrifuge briefly to collect all material on bottom of tube.  
4) Using thermal cycler, incubate samples to digest at 65C for 2 hrs, then stop reaction by 
denaturing at 95C for 10 minutes.  
5) Store DNA at -20C until further analysis 
 
B.4 PCR using Taq JumpStart Readymix 
 
1) Prepare master mix of components: 
Taq JumpStart Readymix 12.5 µl 
Forward Primer (10 uM concentration) 1 µl 
Reverse Primer (10uM concentration) 1 µl 
Water  8.5 µl 
2) Add 23 µl of master mix to 0.5 mL PCR tubes.  
3) Add 2 µl of DNA to each tube (approximately 50-500ng depending on target). Vortex 
gently and centrifuge briefly to collect all material at bottom of tube. 
4) Load samples into thermal cycler, using heated lid. PCR thermal cycler conditions must 
be optimized based on length of fragment and primers.  
Initial parameters:  
5 minutes at 95°C 
30 seconds at 94°C, 30 seconds at 56°C and 30 seconds at 72°C for 30 cycles 
15 minutes at 72°C 
5 min at 10°C 
Hold at 4°C 
5) During reaction, pour 2% agarose gel for electrophoresis and add appropriate comb for 
number of samples.  
6) After reaction, add 1:6 dilution of loading dye per tube (5ul per 25ul sample). Pipet 
gently and load 5-10 µl of sample into each well. Always include ladder and positive 
control.  
7) Gel electrophoresis at 85-90V for approximately 20-40 minutes, depending on size of 
amplicon.  
8) Use UV light (GelReader) to analyze DNA. 
 
